创伤诱导性凝血病仅见于中重度创伤患者四种休克诱导性内皮病(SHINE)表型中的一种:一项探索性分析
欧洲多中心观察性研究纳入损伤严重度评分≥16、伤后2小时内到达创伤中心的成人创伤患者,检测SHINE生物标志物(多配体蛋白聚糖-1、可溶性血栓调节蛋白、肾上腺素)并对凝血与纤溶因子做广泛分析,用层次聚类识别SHINE表型。313例患者聚为四种SHINE表型;表型2糖萼脱落最重、占全队列22%,表现为严重凝血病(凝血酶原、FV、IX、X、XI水平较低)和严重纤溶亢进(PAP与tPA较高、α2-抗纤溶酶较低)。该表型输血需求显著更高,病死率39%对其它表型的23%、15%和14%,而损伤严重度评分相似。作者认为创伤诱导性凝血病仅限于四种SHINE表型中的一种,需进一步研究。
要点
- 313例损伤严重度评分≥16、伤后2小时内到达创伤中心的成人创伤患者,经层次聚类分为四种SHINE表型。
- 表型2糖萼脱落最重,占全队列22%,凝血酶原、FV、IX、X、XI水平较低,PAP与tPA较高、α2-抗纤溶酶较低。
- 表型2输血需求显著更高,病死率39%,其它表型分别为23%、15%和14%,而损伤严重度评分相似。
- 创伤诱导性凝血病仅局限于四种SHINE表型中的一种,并非所有中重度创伤患者共有。
适用人群与场景
- 欧洲多中心成人创伤患者,损伤严重度评分≥16,伤后2小时内到达创伤中心。
- 入院时采集血样用于SHINE生物标志物与凝血、纤溶因子分析。
诊断标准与关键阈值
- SHINE生物标志物为多配体蛋白聚糖-1、可溶性血栓调节蛋白、肾上腺素。
- 采用SHINE生物标志物的层次聚类识别SHINE表型,共识别出四种表型。
研究设计与关键结果
- 欧洲多中心观察性研究,纳入313例损伤严重度评分≥16、伤后2小时内到达创伤中心的成人创伤患者,经层次聚类分为四种SHINE表型。
- 表型2糖萼脱落最重,占全队列22%,表现为严重凝血病:凝血酶原、FV、IX、X、XI水平较低。
- 表型2同时存在严重纤溶亢进:纤溶酶-α2-抗纤溶酶复合物(PAP)与tPA水平较高,α2-抗纤溶酶水平较低。
- 表型2输血需求显著更高,病死率39%,其它表型分别为23%、15%和14%,而损伤严重度评分相似。
证据类型、等级与局限
- 证据类型:欧洲多中心观察性研究(探索性分析)。
- 局限:原文报告需进一步研究(warranting further investigation)。
对床旁实践的改变
- 作者认为创伤诱导性凝血病仅见于四种SHINE表型中的一种(占队列22%),该表型以严重低凝和纤溶亢进为特征,对应更高的输血需求与病死率,需进一步研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Trauma induced coagulopathy remains to be an important cause of high transfusion requirements and mortality and shock induced endotheliopathy (SHINE) has been implicated.
METHODS: European multicenter observational study of adult trauma patients with injury severity score ≥ 16 arriving within 2 h from injury to the trauma centers. Admission blood samples obtained were used for analysis of the SHINE biomarkers (syndecan-1, soluble thrombomodulin, adrenaline) and extensive analysis of coagulation, -and fibrinolytic factors together with collection of clinical data. Hierarchical clustering of the SHINE biomarkers was used to identify the SHINE phenotypes.
RESULTS: The 313 patients clustered into four SHINE phenotypes. Phenotype 2, having the highest glycocalyx shedding, encompassing 22% of the whole cohort, had severe coagulopathy with lower levels of prothrombin, FV, IX, X, XI and severe hyperfibrinolysis with higher plasmin - alpha 2-antiplasmin (PAP) - and tPA levels and lower alpha2 - antiplasmin levels. This phenotype had significantly higher transfusion requirements and higher mortality (39% vs. 23%, 15% and 14%) but similar injury severity score (ISS) compared to the others phenotypes.
CONCLUSIONS: Hierarchical clustering identified four SHINE phenotype in a cohort of trauma patients. Trauma induced coagulopathy was confined to only one of the SHINE phenotypes, encompassing 22% of the total cohort. This phenotype was characterized by severe hypocoagulability and hyperfibrinolysis, which translated to significantly higher transfusion requirements and higher mortality compared to the other SHINE phenotypes with similar injury severity, warranting further investigation.
参考来源
- Johansson PI, Vigstedt M, Curry NS, et al. Trauma induced coagulopathy is limited to only one out of four shock induced endotheliopathy (SHINE) phenotypes among moderate-severely injured trauma patients: an exploratory analysis. Scand J Trauma Resusc Emerg Med. 2024. PMID: 39160625. doi:10.1186/s13049-024-01236-8
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。